| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1487 | 2011 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1305 | 2017 |
| Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016 | 1151 | 2016 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1126 | 2015 |
| Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer The lancet oncology 13 (11), 1141-1151, 2012 | 1089 | 2012 |
| Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012 | 1076 | 2012 |
| Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009 | 1024 | 2009 |
| Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ... Genome research 20 (4), 440-446, 2010 | 921 | 2010 |
| Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 894 | 2019 |
| Management of women who test positive for high-risk types of human papillomavirus: the HART study J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ... The Lancet 362 (9399), 1871-1876, 2003 | 767 | 2003 |
| Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999 | 727 | 1999 |
| New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005 | 677 | 2005 |
| Progress and challenges in screening for early detection of ovarian cancer IJ Jacobs, U Menon Molecular & Cellular Proteomics 3 (4), 355-366, 2004 | 677 | 2004 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015 | 487 | 2015 |
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013 | 457 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021 | 408 | 2021 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 392 | 2017 |
| A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ... Nature genetics 42 (10), 874-879, 2010 | 390 | 2010 |
Ian JacobsPresident & Vice Chancellor, University of New South Wales, Sydney, AustraliaVerified email at unsw.edu.au
